JPH0892113A - Anti-inflammatory drug from rice - Google Patents
Anti-inflammatory drug from riceInfo
- Publication number
- JPH0892113A JPH0892113A JP6254190A JP25419094A JPH0892113A JP H0892113 A JPH0892113 A JP H0892113A JP 6254190 A JP6254190 A JP 6254190A JP 25419094 A JP25419094 A JP 25419094A JP H0892113 A JPH0892113 A JP H0892113A
- Authority
- JP
- Japan
- Prior art keywords
- rice
- product
- present
- koji
- germinated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 90
- 235000009566 rice Nutrition 0.000 title claims abstract description 89
- 239000002260 anti-inflammatory agent Substances 0.000 title claims abstract description 18
- 240000007594 Oryza sativa Species 0.000 title description 72
- 229940124599 anti-inflammatory drug Drugs 0.000 title description 3
- 238000000855 fermentation Methods 0.000 claims abstract description 32
- 230000004151 fermentation Effects 0.000 claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 22
- 238000000605 extraction Methods 0.000 claims abstract description 20
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 18
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 17
- 150000007524 organic acids Chemical class 0.000 claims abstract description 4
- 241000209094 Oryza Species 0.000 claims abstract 18
- 238000000034 method Methods 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 235000021329 brown rice Nutrition 0.000 description 26
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 22
- 239000000203 mixture Substances 0.000 description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 206010061218 Inflammation Diseases 0.000 description 11
- 230000000593 degrading effect Effects 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 230000002366 lipolytic effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010018691 Granuloma Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- -1 polyoxy Ethylene Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004712 air sac Anatomy 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZWPWSXGBDMGKKS-ZDUSSCGKSA-N Cypridina luciferin Chemical class C1=CC=C2C(C=3NC(CCCNC(N)=N)=C4N=C(C(N4C=3)=O)[C@@H](C)CC)=CNC2=C1 ZWPWSXGBDMGKKS-ZDUSSCGKSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 1
- PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- MXZACTZQSGYANA-UHFFFAOYSA-N chembl545463 Chemical compound Cl.C1=CC(OC)=CC=C1C(N=C1)=CN2C1=NC(C)=C2O MXZACTZQSGYANA-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- CYAJEMFRSQGFIG-ISWIILBPSA-N microcystin-LA Natural products CO[C@@H](Cc1ccccc1)[C@@H](C)C=C(C)C=C[C@H](NC(=O)CNC(=O)[C@@H](C)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)C(=C)N(C)C(=O)CC[C@@H](C)C(=O)O)C(=O)O)[C@H](C)C(=O)N CYAJEMFRSQGFIG-ISWIILBPSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
(57)【要約】
【目的】 安全で安価であって、原料供給が安定してお
り、加工が容易で、長期に亘って常用しても安全な抗炎
症剤を提供する。
【構成】 発芽させた米の粉砕物、米または発芽さ
せた米の抽出物、米または発芽させた米の加水物を酵
素分解または麹を作用させたもの、米または発芽させ
た米を抽出するに当たり、その抽出前、抽出と同時また
は抽出後に酵素分解または麹を作用させたもの、米ま
たは発芽させた米の抽出物あるいは酵素分解または麹を
作用させたものに、アルコール発酵あるいは有機酸発酵
を行なったもの、以上それぞれをそのまま、あるいはこ
れを含有してなる抗炎症剤。(57) [Summary] [Purpose] To provide an anti-inflammatory agent that is safe and inexpensive, has a stable supply of raw materials, is easy to process, and is safe even when used regularly for a long period of time. [Structure] Smashed germinated rice, rice or germinated rice extract, rice or germinated rice hydrolyzed with enzymatic decomposition or koji, rice or germinated rice are extracted Prior to the extraction, at the same time as or after the extraction, those subjected to enzymatic decomposition or koji, the extract of rice or sprouted rice or those subjected to enzymatic decomposition or koji, were subjected to alcohol fermentation or organic acid fermentation. An anti-inflammatory agent which is the same as each of the above-mentioned ones or containing the same.
Description
【0001】[0001]
【産業上の利用分野】本発明は、米または発芽させた米
を原料として得られる抗炎症剤に関するものである。TECHNICAL FIELD The present invention relates to an anti-inflammatory agent obtained from rice or sprouted rice as a raw material.
【0002】[0002]
【従来の技術】炎症の原因としては、物理的、化学的な
もの、さらには、微生物による感染、アレルギー反応、
代謝異常などがあげられ、発赤、腫瘍、発熱、疼痛がそ
の主徴である。これらに対し、現在、繁用されている抗
炎症剤には、非ステロイド性抗炎症剤、副腎皮質合成ス
テロイド剤、消炎酵素剤があり、特に副腎皮質合成ステ
ロイド剤は優れた抗炎症効果を発揮している。しかし、
これらは局所的な治療としては非常に優れている反面、
生体機能に対して重大な副作用をもたらすことが、近年
頻繁に言われるようになってきた。非常に効果の強い抗
炎症薬を一時的に使用することによって起こるリバウン
ド現象や、抗炎症薬による薬物炎症など、これらはほん
の1例であり、実際には、その副作用、使用量、使用期
間に重大な問題が数多くあり、安心して使用できないの
が現状である。したがって、炎症に対して、有効で、か
つ、副作用もなく安心して使用できる抗炎症剤は、未だ
開発されていないのが現状である。2. Description of the Related Art Causes of inflammation include physical and chemical ones, and further infection by microorganisms, allergic reaction,
Metabolic disorders are included, and the main symptoms are redness, tumors, fever, and pain. On the other hand, currently widely used anti-inflammatory agents include non-steroidal anti-inflammatory agents, corticosteroid synthetic steroids, and anti-inflammatory enzyme agents, and particularly corticosteroid steroids exert excellent anti-inflammatory effects. are doing. But,
While these are very good local treatments,
In recent years, it has been frequently said that a serious side effect is caused on a biological function. These are just a few examples, such as the rebound phenomenon caused by the temporary use of highly effective anti-inflammatory drugs, and drug inflammation caused by anti-inflammatory drugs. Currently, there are many serious problems that cannot be used with confidence. Therefore, it is the current situation that an anti-inflammatory agent that is effective against inflammation and can be used without any side effect with confidence has not yet been developed.
【0003】一方、米は主食以外に、清酒、焼酎、みり
ん、酢、麹などとして用途開発され、古くから生活に欠
かせないものとなっている。このほかには、美容的用途
として糠袋が知られている。これらは、米を単なる主食
であると見るか、またはせいぜい澱粉源として見ていな
かったということによるものであると思われる。また、
糠袋にしても、皮膚に良いとされ、慣例的にそのまま使
用されてきたのみであり、有効成分という概念もなけれ
ば、その有効成分を利用するという考え方も全くなかっ
たのである。On the other hand, rice has been used as a staple food, as well as sake, shochu, mirin, vinegar, koji, etc., and has long been indispensable for daily life. In addition to this, bran bags are known for cosmetic purposes. It is believed that these are due to the fact that rice was viewed as merely a staple food, or at best not as a starch source. Also,
Even in the case of bran bags, it is said that it is good for the skin, and it has been used as it is conventionally, and there is no concept of an active ingredient, nor is there any idea of utilizing the active ingredient.
【0004】[0004]
【発明が解決しようとする課題】現在、薬剤の人体に対
する副作用が問題となっており、全く副作用がなく、し
かも、長期に亘って常用しても十分に安全な抗炎症剤が
要求されている。本発明は、安全で安価であって、原料
供給が安定しており、加工が容易で、長期に亘って常用
しても全く安全な米からの抗炎症剤を提供することを目
的とするものである。At present, there is a problem of side effects of drugs on the human body, and there is a demand for anti-inflammatory agents that have no side effects and are sufficiently safe even if they are used regularly for a long period of time. . It is an object of the present invention to provide an anti-inflammatory agent from rice which is safe and inexpensive, has a stable supply of raw materials, is easy to process, and is completely safe even after long-term regular use. Is.
【0005】[0005]
【課題を解決するための手段】本発明者らは、動植物合
和すの観点から、主食である米を中心に種々の植物成分
の研究を進めてきた。その過程で、米には今まで予測で
きなかった数多くの可能性および効果があることが判明
してきた。そこで、主食として用いられ、安全性が最も
高いことが実証されている米をテーマとして取り上げ、
米の総合利用研究を行なってきた。そのうちの一つのテ
ーマとして、米からの抗炎症剤について鋭意研究を重ね
てきたのであるが、その過程で、米および発芽させた米
には、抗炎症剤としての効果を有する成分が含有されて
いることを見出し、本発明を完成するに至った。[Means for Solving the Problems] From the viewpoint of animal and plant harmony, the present inventors have conducted research on various plant components centering on rice, which is a staple food. In the process, it has become clear that rice has a number of potential and benefits that were previously unpredictable. Therefore, we picked up rice, which is used as a staple food and proved to have the highest safety, as the theme,
I have been conducting comprehensive utilization research on rice. As one of the themes, we have conducted intensive research on anti-inflammatory agents from rice, and in the process, rice and germinated rice contain ingredients that have the effect of anti-inflammatory agents. That is, the present invention has been completed.
【0006】本発明において、米および発芽させた米に
含有されている抗炎症効果を有する成分は、未だ解明す
るに至っていないが、米および発芽させた米を、下記の
ように処理したものは、抗炎症効果を示すことが判明し
た。 発芽させた米の粉砕物をそのまま、あるいはこれを
含有してなるもの。 米または発芽させた米の抽出物をそのまま、あるい
はこれを含有してなるもの。 米または発芽させた米の加水物を酵素分解または麹
を作用させたものをそのまま、あるいはこれを含有して
なるもの。 米または発芽させた米を抽出するに当たり、その抽
出前、抽出と同時または抽出後に酵素分解または麹を作
用させたものをそのまま、あるいはこれを含有してなる
もの。 米または発芽させた米の抽出物あるいは酵素分解ま
たは麹を作用させたものに、アルコール発酵あるいは有
機酸発酵を行なったものをそのまま、あるいはこれを含
有してなるもの。In the present invention, the component having an anti-inflammatory effect contained in rice and germinated rice has not yet been clarified, but rice and germinated rice treated as described below , Was found to show an anti-inflammatory effect. Sprouted crushed rice as it is or containing it. Rice or germinated rice extract as it is or containing it. Enzyme-decomposed or hydrolyzed rice hydrolyzed as it is, or containing it. When extracting rice or sprouted rice, the one that has been subjected to enzymatic decomposition or koji before or at the same time as or after the extraction is used as it is or containing it. An extract of rice or germinated rice or a product of enzymatic decomposition or koji which has been subjected to alcohol fermentation or organic acid fermentation as it is or containing it.
【0007】ここでいう炎症とは、急性湿疹、接触皮膚
炎、帯状疱疹、創傷、日光皮膚炎、しゅさ様皮膚炎、口
囲皮膚炎、慢性皮膚炎、おむつの皮膚炎、熱傷、、皮膚
欠損創など、炎症により起こる疾患全てを指す。The inflammation referred to herein is acute eczema, contact dermatitis, shingles, wounds, sunburn dermatitis, rosaceous dermatitis, periodermatitis, chronic dermatitis, diaper dermatitis, burns, skin. It refers to all diseases caused by inflammation, such as defective wounds.
【0008】本発明で使用される米とは、ジャポニカ,
インディカ米を問わず、うるち米、および餅米等の玄米
および白米を指し、品種、種類は問わない。さらに、精
白時に出てくる92%以上の赤糠、あるいは92%以下
の白糠を使用してもよく、安価で経済的である。また、
発芽させた米が使用される。なお、有効成分は、熱およ
び光に対して安定であるため、上記の原料は、浸漬、蒸
煮、焙煎(砂焙り、網焙り、熱風焙煎等全てを指す)、
蒸煮焙煎、凍結乾燥等の表面変性、UV照射等の光変
性、パットライス等の加圧焙煎、揚げる等の原料処理を
してもよく、また、効果も変わらなかった。The rice used in the present invention means japonica,
Regardless of indica rice, it refers to non-glutinous rice, brown rice such as sticky rice, and white rice, regardless of variety and type. Further, 92% or more of red rice bran or 92% or less of white rice bran, which appears during whitening, may be used, which is inexpensive and economical. Also,
Germinated rice is used. In addition, since the active ingredient is stable to heat and light, the above raw materials are dipping, steaming, roasting (all sand roasting, net roasting, hot air roasting, etc.),
The raw material treatment such as steam roasting, surface modification such as freeze-drying, photo-modification such as UV irradiation, pressure roasting such as Patrice, and frying may be performed, and the effect was not changed.
【0009】米および発芽させた米は、そのまま用いて
も有効であるが、実用上の面から粉砕して用いるのが好
ましい。米および発芽させた米を粉砕して粉体化するに
は、粉砕機または精米機を用い、一般的な方法で行えば
よい。米を発芽させる場合、胚芽のついた米を水に浸漬
あるいは水を噴霧して発芽させる。発芽させる時の温度
は5〜70℃である。ただし、発芽さえすれば、温度お
よび時間は問わない。また、発芽中に水が腐敗する危険
性がある場合は、腐敗しないように水を取り替えるか、
何らかの防腐を行うのが好ましい。ここで、発芽とは、
発芽する直前から発芽したものまで全てを指す。この発
芽させた米をよく洗浄して用いる。この時、乾燥して用
いてもよい。Although the rice and germinated rice are effective as they are, they are preferably crushed for practical use. In order to pulverize the rice and the sprouted rice into powder, a pulverizer or a rice mill may be used and a general method may be used. When sprouting rice, germinated rice is soaked in water or sprayed with water to germinate. The temperature for germination is 5 to 70 ° C. However, the temperature and time do not matter as long as they germinate. Also, if there is a risk of water spoiling during germination, replace the water so that it does not decay, or
It is preferable to carry out some preservatives. Here, germination means
It refers to everything from just before germination to germinated ones. The germinated rice is washed well before use. At this time, it may be dried before use.
【0010】米または発芽させた米を抽出、あるいは酵
素分解または麹を作用させる場合、原料の米を粉砕して
顆粒あるいは粉体化すると、表面積が大きくなるため効
率がよくなる。粉砕しなくてもよいが、この場合には、
米組織の分解および抽出に長時間を要する。米または発
芽させた米を水抽出する場合、抽出温度は、高温が効率
的であるが、低温でも十分に抽出を行うことができる。
ただし、40℃以下の低温の場合は、pHを酸性あるい
はアルカリ性にするか、防腐剤あるいはアルコールを加
えて、米が腐敗しないように処理することが望ましい。
抽出時間は、有効成分さえ抽出できれば、長くても短く
てもよく、抽出温度により定めればよい。また、抽出
は、加圧下または常圧下で行っても、減圧下で行っても
よい。When extracting rice or germinated rice, or subjecting it to enzymatic decomposition or koji, the raw material rice is pulverized into granules or powders, thereby increasing the surface area and improving efficiency. You don't have to grind, but in this case,
It takes a long time to decompose and extract the rice tissue. When extracting rice or germinated rice with water, a high extraction temperature is effective, but sufficient extraction can be performed even at a low temperature.
However, at a low temperature of 40 ° C. or lower, it is desirable to make the pH acidic or alkaline, or add a preservative or alcohol to treat the rice so that it does not spoil.
The extraction time may be long or short as long as the active ingredient can be extracted, and may be determined depending on the extraction temperature. The extraction may be carried out under pressure, at normal pressure, or under reduced pressure.
【0011】また、米の浸漬水あるいは浸漬水の中です
りつぶした液を用いてもよい。すなわち、米の成分が出
てくる方法ならば何でもよい。水抽出の場合、最も問題
になるのは糊化現象である。糊状になれば、抽出効率が
悪くなるばかりでなく、実作業においては困難を極め
る。これを防ぐためには、アミラーゼを加えて反応させ
るか、塩酸などで酸性にして澱粉を切ってやればよく、
この方法を用いることにより、十分に解決でき、実用上
も全く問題はない。Further, rice immersion water or a liquid mashed in immersion water may be used. In other words, any method may be used as long as the rice ingredients come out. In the case of water extraction, the most problematic is the gelatinization phenomenon. If it becomes pasty, not only the extraction efficiency will deteriorate, but it will be extremely difficult in actual work. In order to prevent this, amylase can be added and reacted, or acidified with hydrochloric acid or the like to cut the starch,
By using this method, it is possible to solve the problem sufficiently and there is no problem in practical use.
【0012】抽出物中の有効成分は、酸,アルカリに安
定であるためか、酸分解抽出、あるいはアルカリ分解抽
出を行うのも有効である。この場合、必要により中和、
脱塩を行う。有機溶媒で抽出する場合も、米はなるべく
微粉砕または粉体化して抽出することが望ましい。有機
溶媒はアルコール,アセトン,n−ヘキサン,メタノー
ル等の一般的な有機溶媒でよいが、人体に対して有害な
ものは抽出後、溶媒を完全に除去する必要があるので安
全なものがよい。Since the active ingredient in the extract is stable to acid and alkali, it is also effective to perform acid decomposition extraction or alkali decomposition extraction. In this case, neutralize if necessary,
Desalt. Also when extracting with an organic solvent, it is desirable to pulverize or pulverize rice as much as possible before extracting. The organic solvent may be a general organic solvent such as alcohol, acetone, n-hexane, methanol, etc., but if it is harmful to the human body, it is necessary to completely remove the solvent after extraction, so a safe one is preferable.
【0013】米あるいは発芽させた米を酵素分解する場
合、まず、米あるいは発芽させた米に加水した後、酵素
を添加する。加水量は収率、作業性、最終使用目的など
に応じて適宜選定する。また、加水温度は酵素あるいは
麹の至適温度が効率的であるが、低温でも長時間おけば
酵素分解は充分に行われる。ただし、40℃以下の低温
の場合は、なんらかの防腐を行うことが必要である。ま
た、分解さえすれば温度は高温でもよい。分解時間は温
度等に左右されるが、分解さえ行われれば短くても長く
てもよい。When enzymatically decomposing rice or sprouted rice, first, water is added to the rice or sprouted rice, and then an enzyme is added. The amount of water added is appropriately selected depending on the yield, workability, purpose of final use, and the like. The optimum water temperature is the optimum temperature of the enzyme or koji, but enzymatic decomposition is sufficiently carried out even at low temperatures for a long time. However, if the temperature is lower than 40 ° C., some kind of preservative is required. The temperature may be high as long as it is decomposed. The decomposition time depends on the temperature and the like, but may be short or long as long as the decomposition is performed.
【0014】ここで使用する酵素は、澱粉分解酵素、蛋
白分解酵素、脂肪分解酵素、繊維分解酵素、リグニン分
解酵素およびペクチン分解酵素のうち1種または2種以
上である。また、麹を使用する場合においては、加水
量、作用温度、作用時間は、酵素分解の場合と同様であ
る。使用する麹は、一般に使用される麹でよく、麹菌の
種類および品種は問わない。The enzyme used here is one or more of starch degrading enzyme, proteolytic enzyme, lipolytic enzyme, fiber degrading enzyme, lignin degrading enzyme and pectin degrading enzyme. When koji is used, the amount of water added, the temperature of action and the time of action are the same as in the case of enzymatic decomposition. The koji to be used may be generally used koji, and the type and variety of koji mold are not limited.
【0015】さらに、前記の抽出を行うに当たり、抽出
の前、抽出と同時または抽出の後に、上記の酵素分解お
よび麹を作用させてもよい。ここで、抽出と同時に酵素
分解あるいは麹を作用させる場合、具体的には、有機溶
媒中で酵素分解あるいは麹を作用させるか、減圧抽出下
で酵素分解あるいは麹を作用させるなどの方法により行
う。Further, in carrying out the above-mentioned extraction, the above-mentioned enzymatic decomposition and koji may be allowed to act before, simultaneously with or after the extraction. Here, when enzymatic decomposition or koji is allowed to act simultaneously with extraction, specifically, enzymatic decomposition or koji is allowed to act in an organic solvent, or enzymatic decomposition or koji is allowed to act under reduced pressure extraction.
【0016】本発明においては、上記の各処理を行なう
と同時または処理後、アルコール発酵あるいは乳酸発
酵、酢酸発酵等の有機酸発酵を行えば、さらに有効的で
ある。このアルコール発酵を行う場合、上記のようにし
て得られた抽出物、酵素分解物(酵素分解、抽出を組み
合わせて得られるものも含む)または麹を作用させたも
のをそのまま、または圧搾、濾過して得た液をアルコー
ル発酵させる。なお、酵素分解とアルコール発酵は同時
に行ってもよい。すなわち、米または発芽させた米に加
水後、酵素または麹、さらに酒母または酵母を添加し
て、糖化、アルコール発酵を行う。大量に製造する場
合、糖化と発酵のバランスを考えながら、清酒醸造に準
じて3段階あるいは何段階にも分けて、米または発芽さ
せた米を添加するのが望ましい。特に少量を処理する場
合においては、一度に添加するのが有効である。糖化お
よびアルコール発酵は10〜24日間行い、この際、腐
敗が心配な場合は、酸を添加するか、発酵の阻害になら
ない適当な防腐を施す。In the present invention, it is more effective if the organic acid fermentation such as alcohol fermentation, lactic acid fermentation, or acetic acid fermentation is carried out at the same time as or after the above respective treatments. When carrying out this alcoholic fermentation, the extract obtained as described above, the enzymatic decomposition product (including those obtained by combining enzymatic decomposition and extraction) or the one obtained by allowing koji to act as it is, or after pressing and filtering The obtained liquid is subjected to alcohol fermentation. In addition, enzymatic decomposition and alcohol fermentation may be performed simultaneously. That is, after water is added to rice or sprouted rice, an enzyme or koji, and then sake mother or yeast are added to perform saccharification and alcohol fermentation. When producing in large quantities, considering the balance between saccharification and fermentation, it is desirable to add rice or sprouted rice in three or more stages according to sake brewing. Especially when treating a small amount, it is effective to add them all at once. Saccharification and alcoholic fermentation are carried out for 10 to 24 days. At this time, when decay is a concern, acid is added or suitable preservative that does not hinder fermentation is applied.
【0017】アルコール発酵を行うと、ベトツキがなく
なること、濃縮がしやすく有効成分の濃縮が容易になる
ことなどの利点もある。乳酸発酵を行う場合は、アルコ
ール発酵の場合と同様で、この場合は、酒母または酵母
の代わりに乳酸菌を添加して乳酸発酵を行う。乳酸発酵
は一般的な常法によって行い、乳酸菌の種類および乳酸
発酵の条件は問わない。Alcohol fermentation has advantages such as elimination of stickiness, easy concentration, and easy concentration of the active ingredient. When carrying out lactic acid fermentation, it is similar to the case of alcoholic fermentation. In this case, lactic acid bacteria are added instead of liquor or yeast to carry out lactic acid fermentation. Lactic acid fermentation is carried out by a general ordinary method, and the type of lactic acid bacterium and the conditions for lactic acid fermentation do not matter.
【0018】次に、酢酸発酵の場合は、上記のようにし
て得られた発酵物をそのまま、あるいは希釈してアルコ
ール4〜5%にした後、酢酸菌を添加して酢酸発酵を行
う。また、アルコールのないものは、アルコールを添加
して酢酸発酵を行えばよい。酢酸発酵は一般的な常法に
よって行い、酢酸菌の種類および酢酸発酵の条件は問わ
ない。Next, in the case of acetic acid fermentation, the fermented product obtained as described above is used as it is or after being diluted to 4-5% of alcohol, acetic acid bacteria are added to carry out acetic acid fermentation. For alcohol-free products, acetic acid fermentation may be carried out by adding alcohol. Acetic acid fermentation is carried out by a general ordinary method, and the type of acetic acid bacterium and the conditions of acetic acid fermentation are not limited.
【0019】以上のようにして得られた本発明品は、残
渣を分離することなくそのまま、あるいは圧搾、濾過し
て用いる。そのまま用いるときは、殺菌あるいは除菌を
して製品とする。なお、必要により酵母による通気発
酵、アルコール沈殿、合成吸着剤等で除糖を行なっても
よい。また、本発明品を配合する場合は、実際の用途に
応じ、クリーム状、乳液状、化粧水状などの剤型とす
る。他の配合成分は、通常用いられるものいずれでもよ
く、さらに、他の薬効剤を併用してもよい。The product of the present invention obtained as described above is used as it is without separating the residue, or after being pressed and filtered. When used as is, sterilize or sterilize the product. If necessary, aeration fermentation with yeast, alcohol precipitation, synthetic adsorbents and the like may be used for sugar removal. When the product of the present invention is blended, it is made into a cream-like, emulsion-like, or lotion-like formulation depending on the actual use. The other compounding ingredients may be any of those usually used, and further, other medicinal agents may be used in combination.
【0020】本発明品の抗炎症作用について調べた結果
を以下に記載する。 (1) カラゲニン肉芽腫抑制実験 1群3匹の雄性ラット(6〜8週齢)の背部体毛を除毛
後、皮下に空気を注入して空気嚢を作成し、24時間
後、この空気嚢内にカラゲニンを注入し、炎症を惹起し
た。炎症惹起後、4日目よりエキスを1日2回、決まっ
た時間に塗布し、1週間続けた。なお、水を塗布しただ
けのものをネガティブコントロールとし、インドメタシ
ンを塗布しただけのものをポジティブコントロールとし
た。塗布1週間後、ラットを炭酸ガスにて窒息死させ、
炎症による肉芽腫内液量と肉芽腫の重量を測定し、抑制
率を求めた。その結果を表1に示す。The results of examining the anti-inflammatory effect of the product of the present invention are described below. (1) Carrageenin Granuloma Inhibition Experiment After removing hair from the back hair of 3 male rats (6 to 8 weeks old) per group, air was subcutaneously injected to create an air sac, and 24 hours later, in this air sac Carrageenin was injected into the rat to induce inflammation. From the 4th day after the induction of inflammation, the extract was applied twice a day at a predetermined time and continued for 1 week. In addition, the one to which only water was applied was used as a negative control, and the one to which indomethacin was applied was used as a positive control. One week after the application, the rat was suffocated with carbon dioxide gas,
The amount of fluid in granuloma due to inflammation and the weight of granuloma were measured to determine the inhibition rate. The results are shown in Table 1.
【0021】[0021]
【表1】 [Table 1]
【0022】(2) 好中球由来活性酸素生成抑制およ
び消去効果 ラットより単離した好中球浮遊液にウミホタル・ルシフ
ェリン誘導体(MCLA)と本発明品を添加し、試験管
中にて5分間インキュベーションした。フォトンカウン
ターにて測定を開始し、5秒後に好中球刺激剤(fML
P)を添加し、発生したフォトン数(活性酸素量)を測
定した。なお、本発明品を添加せずにfMLPを添加し
た時に発生するフォトン数を対照とした。結果を表2に
示す。(2) Inhibition of neutrophil-derived active oxygen production and scavenging effect Cypridina luciferin derivative (MCLA) and the product of the present invention were added to a neutrophil suspension isolated from a rat, and the mixture was placed in a test tube for 5 minutes. Incubated. Start measurement with a photon counter, and 5 seconds later, a neutrophil stimulant (fML
P) was added and the number of photons generated (amount of active oxygen) was measured. The number of photons generated when fMLP was added without adding the product of the present invention was used as a control. Table 2 shows the results.
【0023】[0023]
【表2】 [Table 2]
【0024】表1および表2より、本発明品は、抗炎症
作用を持ち、炎症の治療効果に有効であることが判明し
た。 (3) ヒトでの臨床実験 まず、各種疾患のパネラーに、本発明品を毎日朝晩2
回、患部に塗布し、1ケ月間継続使用させ、その経過を
診断し、本発明品の有用性を判断した。塗布の仕方は、
直接か、あるいは脱脂綿等の道具を使用するなど、一定
量が塗布できるような方法であればよいとした。結果を
表3および表4に示した。From Tables 1 and 2, it was found that the product of the present invention has an anti-inflammatory effect and is effective in treating inflammation. (3) Clinical Experiments in Human First, the product of the present invention is applied to panelists of various diseases every morning and evening.
It was applied to the affected area once and continuously used for 1 month, the progress was diagnosed, and the usefulness of the product of the present invention was judged. How to apply is
The method can be applied directly, or by using a tool such as absorbent cotton, as long as a certain amount can be applied. The results are shown in Tables 3 and 4.
【0025】なお、パネラーは、各本発明品、各疾患に
対して10名以上で行なった。判定は「著明改善」「改
善」「やや改善」「変化なし」「中止」と分け、有用率
(著明改善+改善+やや改善の全体の割合)で出した。
また、判定は専門の医師により行なった。The panelists were used by 10 or more persons for each product of the present invention and each disease. The judgment was divided into “significant improvement”, “improvement”, “slight improvement”, “no change”, and “discontinuation”, and the usefulness rate (significant improvement + improvement + total improvement) was given.
The judgment was performed by a specialist doctor.
【0026】[0026]
【表3】 [Table 3]
【0027】[0027]
【表4】 [Table 4]
【0028】表3および表4から分かるように、本発明
品全てにおいて、各種炎症に対する抗炎症効果があるこ
とが判明した。以上のように、本発明は、様々な炎症に
対して、米という安全なものから非常に優れた効果を有
する抗炎症剤を得たのである。なお、実施例およびそれ
に伴なうデータは、玄米の場合について記載した。白米
および92%以下の白糠の場合についても同様の効果が
認められた。As can be seen from Tables 3 and 4, all of the products of the present invention were found to have an anti-inflammatory effect against various inflammations. As described above, the present invention has obtained an anti-inflammatory agent having a very excellent effect from various safe substances such as rice against various inflammations. The examples and the data associated therewith are described for brown rice. Similar effects were observed in the case of white rice and white rice bran with a content of 92% or less.
【0029】[0029]
(実施例1)胚芽のついたままの米1kgを25℃の水
につけ、3日間浸漬させ、米を発芽させた。この発芽米
をよく洗浄した後、50℃で24時間乾燥し、その後、
細かく微粉砕し、本発明品990gを得た。 (実施例2)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に水1500mlを添加、塩酸で
pHを落とし10日間放置した。その後、絞り機で絞
り、得た清澄液を中和して、本発明品1200mlと残
渣760gを得た。(Example 1) 1 kg of rice without germ was soaked in water at 25 ° C for 3 days to germinate rice. After thoroughly washing the germinated rice, it is dried at 50 ° C. for 24 hours, and then,
The product was finely pulverized to obtain 990 g of the product of the present invention. (Example 2) Brown rice was crushed to obtain a crushed brown rice product 500
g was obtained. 1500 ml of water was added to this pulverized product, the pH was lowered with hydrochloric acid, and the mixture was left for 10 days. Then, it was squeezed with a squeezing machine to neutralize the resulting clear liquid to obtain 1200 ml of the product of the present invention and 760 g of a residue.
【0030】(実施例3)実施例1で得られた本発明品
500gを用いて、実施例2と同様の操作を行い、別の
本発明品1190mlを得た。 (実施例4)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に液化酵素10gと水1500m
lを添加した。その後、徐々に温度を上げていき、5分
間煮沸抽出した後、冷却した。その後、絞り機で絞り、
本発明品1420mlと残渣560gを得た。Example 3 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 2 was carried out to obtain another 1190 ml of the product of the present invention. (Example 4) Brown rice is crushed to obtain 500 crushed brown rice.
g was obtained. Liquefaction enzyme 10g and water 1500m to this crushed material
1 was added. Then, the temperature was gradually raised, and the mixture was boiled and extracted for 5 minutes and then cooled. After that, squeeze with a wringer,
1420 ml of the product of the present invention and 560 g of a residue were obtained.
【0031】(実施例5)実施例1で得られた本発明品
500gを用いて、実施例4と同様の操作を行い、別の
本発明品1400mlを得た。 (実施例6)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に2N−NaOH1500mlを
添加して5日間放置した。その後、絞り機で絞り、清澄
液1350mlと残渣650gを得た。この清澄液を1
0N−HCLで中和して、本発明品1480mlを得
た。Example 5 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 4 was carried out to obtain 1400 ml of another product of the present invention. (Example 6) Brown rice is crushed by a crusher to obtain crushed brown rice 500
g was obtained. 1500 ml of 2N-NaOH was added to this pulverized product and the mixture was left for 5 days. Then, it was squeezed with a squeezing machine to obtain 1350 ml of the clear liquid and 650 g of the residue. 1 of this clarified liquid
It was neutralized with 0N-HCL to obtain 1480 ml of the product of the present invention.
【0032】(実施例7)実施例1で得られた本発明品
500gを用いて、実施例6と同様の操作を行い、別の
本発明品1490mlを得た。 (実施例8)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に95%エタノール1500ml
を添加して、5日間放置した。その後、絞り機で絞り、
清澄液1300mlと残渣650gを得た。この清澄液
に水2000mlを添加し、ロータリーエバポレーター
で濃縮し、本発明品1500mlを得た。Example 7 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 6 was carried out to obtain another 1490 ml of the product of the present invention. (Embodiment 8) Brown rice is crushed to obtain a crushed brown rice product 500
g was obtained. 1500 ml of 95% ethanol is added to this pulverized product.
Was added and left for 5 days. After that, squeeze with a wringer,
1300 ml of clear liquid and 650 g of residue were obtained. 2000 ml of water was added to this clarified solution, and the mixture was concentrated by a rotary evaporator to obtain 1500 ml of the product of the present invention.
【0033】(実施例9)実施例1で得られた本発明品
500gを用いて、実施例8と同様の操作を行い、別の
本発明品1500mlを得た。 (実施例10)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に麹300g、水1500ml
を加え、55℃で20時間放置した。その後、絞り機で
絞り、本発明品1230mlと残渣1000gを得た。Example 9 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 8 was carried out to obtain another 1500 ml of the product of the present invention. (Example 10) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained. 300 g of koji and 1500 ml of water
Was added and the mixture was allowed to stand at 55 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1230 ml of the product of the present invention and 1000 g of a residue.
【0034】(実施例11)実施例1で得られた本発明
品500gを用いて、実施例10と同様の操作を行い、
別の本発明品1210mlを得た。 (実施例12)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に蛋白分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1310mlと残渣670gを得
た。(Example 11) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 10 was carried out,
1210 ml of another product of the present invention was obtained. (Example 12) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. 2 g of protease and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, the product was squeezed with a squeezing machine to obtain 1310 ml of the product of the present invention and 670 g of a residue.
【0035】(実施例13)実施例1で得られた本発明
品500gを用いて、実施例12と同様の操作を行い、
別の本発明品1380mlを得た。 (実施例14)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に脂肪分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1290mlと残渣680gを得
た。Example 13 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 12 was carried out,
Another 1380 ml of the product of the present invention was obtained. (Example 14) Brown rice is crushed to obtain 50 crushed brown rice.
0 g was obtained. 2 g of lipolytic enzyme and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1290 ml of the product of the present invention and 680 g of a residue.
【0036】(実施例15)実施例1で得られた本発明
品500gを用いて、実施例14と同様の操作を行い、
別の本発明品1360mlを得た。 (実施例16)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に繊維分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1330mlと残渣650gを得
た。(Example 15) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 14 was carried out,
Another 1360 ml of the product of the present invention was obtained. (Example 16) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. 2 g of fiber-degrading enzyme and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, the product was squeezed with a squeezing machine to obtain 1330 ml of the product of the present invention and 650 g of a residue.
【0037】(実施例17)実施例1で得られた本発明
品500gを用いて、実施例16と同様の操作を行い、
別の本発明品1370mlを得た。 (実施例18)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に澱粉分解酵素2gと水150
0mlを加え、55℃で20時間放置した。その後、絞
り機で絞り、本発明品1380mlと残渣600gを得
た。Example 17 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 16 was carried out,
Another 1370 ml of the product of the present invention was obtained. (Example 18) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained. 2g starch degrading enzyme and 150g water
0 ml was added and the mixture was left at 55 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1380 ml of the product of the present invention and 600 g of a residue.
【0038】(実施例19)実施例1で得られた本発明
品500gを用いて、実施例18と同様の操作を行い、
別の本発明品1400mlを得た。 (実施例20)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物にペクチン分解酵素2gと水1
500mlを加え、50℃で20時間放置した。その
後、絞り機で絞り、本発明品1320mlと残渣660
gを得た。Example 19 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 18 was carried out,
Another 1400 ml of the product of the present invention was obtained. (Example 20) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. Add 2 g of pectin-degrading enzyme and 1 part of water to this ground product.
500 ml was added and left at 50 ° C. for 20 hours. After that, squeezing with a squeezing machine, 1320 ml of the present invention product and residue 660
g was obtained.
【0039】(実施例21)実施例1で得られた本発明
品500gを用いて、実施例20と同様の操作を行い、
別の本発明品1300mlを得た。 (実施例22)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に蛋白分解酵素2g、脂肪分解
酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペク
チン分解酵素2gと水1500mlを加え、50℃で2
0時間放置した。その後、絞り機で絞り、本発明品14
20mlと残渣560gを得た。Example 21 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 20 was carried out,
Another 1300 ml of the product of the present invention was obtained. (Example 22) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. To this pulverized product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 ml of water were added, and the mixture was heated at 50 ° C. for 2 hours.
It was left for 0 hours. After that, the product of the present invention 14
20 ml and 560 g of residue were obtained.
【0040】(実施例23)実施例1で得られた本発明
品500gを用いて、実施例22と同様の操作を行い、
別の本発明品1440mlを得た。 (実施例24)実施例22と同様の操作をして、米の酵
素分解物2000gを得た。その後、徐々に温度を上げ
ていき、5分間煮沸抽出した後、冷却した。その後、絞
り機で絞り、本発明品1400mlと残渣550gを得
た。(Example 23) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 22 was carried out,
Another 1440 ml of the product of the present invention was obtained. (Example 24) The same operation as in Example 22 was carried out to obtain 2000 g of an enzymatic decomposition product of rice. Then, the temperature was gradually raised, and the mixture was boiled and extracted for 5 minutes and then cooled. Then, it was squeezed with a squeezing machine to obtain 1400 ml of the product of the present invention and 550 g of a residue.
【0041】(実施例25)実施例1で得られた本発明
品500gを用いて、実施例24と同様の操作を行い、
別の本発明品1420mlを得た。 (実施例26)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に麹300gと40%エタノー
ル1500mlを加え、55℃で48時間放置した。そ
の後、絞り機で絞り、清澄液1300mlと残渣850
gを得た。その後、清澄液に1000mlの水を加水
し、ロータリーエバポレーターで濃縮し、本発明品13
00mlを得た。Example 25 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 24 was carried out,
1420 ml of another product of the present invention was obtained. (Example 26) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained. To this crushed product, 300 g of koji and 1500 ml of 40% ethanol were added, and the mixture was left at 55 ° C. for 48 hours. After that, squeeze with a squeezing machine and clarified liquid 1300 ml and residue 850
g was obtained. Then, 1000 ml of water was added to the clarified liquid, and the mixture was concentrated by a rotary evaporator to obtain the product 13 of the present invention.
00 ml was obtained.
【0042】(実施例27)実施例1で得られた本発明
品500gを用いて、実施例26と同様の操作を行い、
別の本発明品1300mlを得た。 (実施例28)実施例4と同様にして、米の抽出物20
00gを得た。この抽出物に蛋白分解酵素2g、脂肪分
解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペ
クチン分解酵素2gを添加し、50℃で24時間放置し
た。その後、絞り機で絞り、本発明品1400mlと残
渣580gを得た。Example 27 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 26 was carried out,
Another 1300 ml of the product of the present invention was obtained. (Example 28) Rice extract 20 was prepared in the same manner as in Example 4.
00g was obtained. To this extract, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme and 2 g of pectin degrading enzyme were added, and the mixture was left at 50 ° C. for 24 hours. Then, it was squeezed with a squeezing machine to obtain 1400 ml of the product of the present invention and 580 g of a residue.
【0043】(実施例29)実施例1で得られた本発明
品500gを用いて、実施例28と同様の操作を行い、
別の本発明品1390mlを得た。 (実施例30)実施例22と同様にして、米の酵素分解
抽出物2000gを得た。この酵素分解抽出物に酵母を
添加し、16日間アルコール発酵した。その後、絞り機
で絞り、本発明品1880mlと残渣80gを得た。Example 29 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 28 was carried out,
Another 1390 ml of the product of the present invention was obtained. (Example 30) In the same manner as in Example 22, 2000 g of an enzyme-decomposed extract of rice was obtained. Yeast was added to this enzyme-decomposed extract, and alcoholic fermentation was carried out for 16 days. Then, it was squeezed with a squeezing machine to obtain 1880 ml of the product of the present invention and 80 g of a residue.
【0044】(実施例31)実施例1で得られた本発明
品500gを用いて、実施例30と同様の操作を行い、
別の本発明品1800mlを得た。 (実施例32)実施例22と同様にして、米の酵素分解
抽出物2000gを得た。この酵素分解抽出物を煮沸殺
菌した後、37℃まで冷却し、前もって乳酸菌を培養し
たスターター200mlを添加後、よく攪拌密封し、3
7℃で2日間乳酸発酵を行った。その後、絞り機で絞
り、本発明品1380mlと残渣590gを得た。(Example 31) The same operation as in Example 30 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1800 ml of the product of the present invention was obtained. (Example 32) In the same manner as in Example 22, 2000 g of an enzyme-decomposed extract of rice was obtained. The enzyme-decomposed extract was sterilized by boiling, cooled to 37 ° C., 200 ml of a starter in which lactic acid bacteria had been cultured in advance was added, and the mixture was well stirred and sealed, and
Lactic acid fermentation was performed at 7 ° C for 2 days. Then, it was squeezed with a squeezing machine to obtain 1380 ml of the product of the present invention and 590 g of a residue.
【0045】(実施例33)実施例1で得られた本発明
品500gを用いて、実施例32と同様の操作を行い、
別の本発明品1400mlを得た。 (実施例34)実施例22で得られた本発明品1000
mlに95%エタノール80mlを添加し、20日間酢
酸発酵を行った。その後、濾過をし、本発明品990m
lを得た。(Example 33) The same operation as in Example 32 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1400 ml of the product of the present invention was obtained. (Example 34) The product 1000 of the present invention obtained in Example 22.
80 ml of 95% ethanol was added to ml, and acetic acid fermentation was performed for 20 days. Then, it is filtered and the product of the present invention 990 m
1 was obtained.
【0046】(実施例35)実施例1で得られた本発明
品500gを用いて、実施例34と同様の操作を行い、
別の本発明品1000mlを得た。以上の実施例で得た
本発明品を配合して化粧水タイプおよび乳液タイプとす
る場合の実施例について、次に記載する。なお、配合例
は以下の実施例に限定されるものではない。(Example 35) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 34 was carried out,
Another 1000 ml of the product of the present invention was obtained. Examples of the case where the products of the present invention obtained in the above examples are blended into a lotion type and an emulsion type will be described below. The formulation examples are not limited to the examples below.
【0047】(実施例36) 実施例22で得られた本発明品 10.0重量% ソルビトール 3.0重量% グリセリン 5.0重量% 精製水 76.4重量% アラントイン 0.1重量% ポリオキシエチレンヒマシ油誘導体 0.5重量% エタノール 5 重量% 以上の配合材料を常法により混合溶解し、化粧水タイプ
の製品を得た。(Example 36) The product of the present invention obtained in Example 22 10.0% by weight sorbitol 3.0% by weight glycerin 5.0% by weight purified water 76.4% by weight allantoin 0.1% by weight polyoxy Ethylene castor oil derivative 0.5% by weight Ethanol 5% by weight The above ingredients were mixed and dissolved by a conventional method to obtain a lotion type product.
【0048】(実施例37) 実施例30で得られた本発明品 20.0重量% ステアリン酸 1.3重量% セタノール 0.7重量% ミツロウ 2.0重量% ポリオキシエチレン(11)モルオレイン酸エステル 1.2重量% グリセリンモノステアリン酸エステル 0.8重量% クインスシード抽出液(5%水溶液) 15.0重量% ジプロピレングリコール 5.0重量% エタノール 3.0重量% メチルパラベン 0.3重量% 香料 0.3重量% 精製水 50.4重量%(Example 37) The product of the present invention obtained in Example 30 20.0% by weight Stearic acid 1.3% by weight Cetanol 0.7% by weight Beeswax 2.0% by weight Polyoxyethylene (11) mol oleic acid Ester 1.2 wt% Glycerin monostearate 0.8 wt% Quinceseed extract (5% aqueous solution) 15.0 wt% Dipropylene glycol 5.0 wt% Ethanol 3.0 wt% Methylparaben 0.3 wt% Fragrance 0.3% by weight Purified water 50.4% by weight
【0049】精製水にジプロピレングリコールを加え、
加熱攪拌し、温度を70℃に保持し、これに本発明品、
クインスシード抽出液、香料、エタノール以外の原料を
加えて攪拌し、次に、ホモジナイザーで均一に乳化させ
る。得られた乳化液を冷却しながら攪拌下に、残りのも
のを徐々に加え、室温に冷却して乳液タイプの製品を得
た。Dipropylene glycol was added to purified water,
The mixture is heated and stirred, and the temperature is maintained at 70 ° C.
A quince seed extract, a fragrance, and ingredients other than ethanol are added and stirred, and then uniformly emulsified with a homogenizer. The remaining emulsion was gradually added to the obtained emulsion with stirring while cooling, and the mixture was cooled to room temperature to obtain an emulsion type product.
【0050】[0050]
【発明の効果】本発明によれば、継続的に外用すること
により、簡単に全く安全で、しかも、抗炎症効果を持つ
優れた抗炎症剤が得られる。米は今までほとんど主食で
あったため、食以外の新規な分野での製法、利用用途は
ほとんど開発されていなかった。さらに、米は今まで主
食とされてきたものであり、安全性も十分に実証されて
いるものである。すなわち、本発明は、非常に優れた抗
炎症剤を見出したばかりでなく、米の過剰生産といわれ
る現在、新たな利用用途を見出したこと、および米のイ
メージアップによる消費拡大を図り得ることは極めて有
意義なことである。INDUSTRIAL APPLICABILITY According to the present invention, an excellent anti-inflammatory agent which is simply and completely safe and has an anti-inflammatory effect can be obtained by continuous external application. Up until now, rice has been the staple food, so little has been developed about its manufacturing method and use in new fields other than food. Furthermore, rice has been the staple food until now, and its safety has been well demonstrated. That is, the present invention has not only found a very excellent anti-inflammatory agent, but has now been found to be a new use application, which is said to be overproduction of rice, and it is extremely possible to increase consumption by improving the image of rice. It is meaningful.
Claims (5)
いはこれを含有してなる抗炎症剤。1. An anti-inflammatory agent which is a crushed product of germinated rice as it is or contains it.
ま、あるいはこれを含有してなる抗炎症剤。2. An anti-inflammatory agent comprising rice or a germinated rice extract as it is or containing the same.
解または麹を作用させたものをそのまま、あるいはこれ
を含有してなる抗炎症剤。3. An anti-inflammatory agent which is obtained by enzymatically decomposing rice or a hydrolyzed rice germinated product or by allowing koji to act, or containing the same.
り、その抽出前、抽出と同時または抽出後に酵素分解ま
たは麹を作用させたものをそのまま、あるいはこれを含
有してなる抗炎症剤。4. An anti-inflammatory agent, which is obtained by extracting rice or sprouted rice with or without enzymatic decomposition or koji before extraction, simultaneously with extraction, or after extraction.
酵素分解または麹を作用させたものに、アルコール発酵
あるいは有機酸発酵を行なったものをそのまま、あるい
はこれを含有してなる抗炎症剤。5. An anti-inflammatory agent comprising the extract of rice or germinated rice or the product of enzymatic decomposition or koji which has been subjected to alcohol fermentation or organic acid fermentation as it is or containing it.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6254190A JPH0892113A (en) | 1994-09-26 | 1994-09-26 | Anti-inflammatory drug from rice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6254190A JPH0892113A (en) | 1994-09-26 | 1994-09-26 | Anti-inflammatory drug from rice |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0892113A true JPH0892113A (en) | 1996-04-09 |
Family
ID=17261497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6254190A Pending JPH0892113A (en) | 1994-09-26 | 1994-09-26 | Anti-inflammatory drug from rice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0892113A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997037674A1 (en) * | 1996-04-05 | 1997-10-16 | Kirin Beer Kabushiki Kaisha | Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof |
JP2006193487A (en) * | 2005-01-14 | 2006-07-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
KR100717996B1 (en) * | 2004-12-10 | 2007-05-14 | 주식회사 유니젠 | Pharmaceutical composition comprising rice extract |
JP2011093880A (en) * | 2009-10-02 | 2011-05-12 | Geo Co Ltd | Anti-inflammatory composition, and skin preparation for external use, cosmetic and health food containing the same |
CN104258038A (en) * | 2014-10-11 | 2015-01-07 | 赵砚霞 | Traditional Chinese medical composition for treating liver meridian fire exuberance type herpes zoster |
CN104288597A (en) * | 2014-09-19 | 2015-01-21 | 魏绍良 | Traditional Chinese medicine composition for treating herpes zoster |
-
1994
- 1994-09-26 JP JP6254190A patent/JPH0892113A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997037674A1 (en) * | 1996-04-05 | 1997-10-16 | Kirin Beer Kabushiki Kaisha | Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof |
US6284290B1 (en) | 1996-04-05 | 2001-09-04 | Kirin Beer Kabushiki Kaisha | Substance containing proteins and insoluble dietary fibers derived from the germinated seed of a grass family plant and uses thereof |
US6348221B1 (en) | 1996-04-05 | 2002-02-19 | Kirin Beer Kabushiki Kaisha | Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof |
US6475533B2 (en) | 1996-04-05 | 2002-11-05 | Kirin Beer Kabushiki Kaisha | Substance containing proteins and insoluble dietary fibers derived from the germinated seed of a grass family plant and uses thereof |
KR100717996B1 (en) * | 2004-12-10 | 2007-05-14 | 주식회사 유니젠 | Pharmaceutical composition comprising rice extract |
JP2006193487A (en) * | 2005-01-14 | 2006-07-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2011093880A (en) * | 2009-10-02 | 2011-05-12 | Geo Co Ltd | Anti-inflammatory composition, and skin preparation for external use, cosmetic and health food containing the same |
CN104288597A (en) * | 2014-09-19 | 2015-01-21 | 魏绍良 | Traditional Chinese medicine composition for treating herpes zoster |
CN104258038A (en) * | 2014-10-11 | 2015-01-07 | 赵砚霞 | Traditional Chinese medical composition for treating liver meridian fire exuberance type herpes zoster |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07252129A (en) | Epidermal stratum corneum health enhancer from rice | |
JPH0741426A (en) | Active oxygen scavenger from rice | |
JP3367709B2 (en) | Cosmetics from rice | |
JP3811198B2 (en) | Antiallergic agent from rice | |
JPH08119870A (en) | Turnover normalizer from rice | |
JPH0892113A (en) | Anti-inflammatory drug from rice | |
JP3811197B2 (en) | Helicobacter pylori disinfectant from rice | |
JP2002284632A (en) | Extinction substance for superoxide anion extracted from sake lees as effective component | |
JP3283642B2 (en) | Hair restorer from rice | |
JPH0710767A (en) | Skin remedy from rice | |
JPH0873367A (en) | Atopic dermatitis preventive and therapeutic agent from rice | |
CN115444791A (en) | Olive leaf fermented extract and its preparation method and application | |
JP3779740B2 (en) | Agents for preventing and treating obesity from rice | |
CN108315132B (en) | Aloe vera health-care wine and production process thereof | |
JP3779735B2 (en) | Treatment for bed slippage from rice | |
CN108165399B (en) | A kind of green money willow dry beer with hypoglycemic and hepatoprotective effect and preparation process thereof | |
JP3795541B2 (en) | Lipid peroxide inhibitor from rice | |
JPH07165595A (en) | Lipid metabolism improver from rice | |
JP3795543B2 (en) | 5α-reductase inhibitor | |
JPH06298660A (en) | Cancer preventive and therapeutic agent from rice | |
JPH07165557A (en) | Acne prevention and treatment agent from rice | |
JPH07187962A (en) | Gray hair improver | |
JPH06340540A (en) | Anti-atherogenic agent from rice | |
CN108451798A (en) | A kind of preparation method of the plant fermentation composition with acne-removing | |
JPH07267847A (en) | Stain remover from rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051004 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051205 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060110 |